The relation of regional cerebral perfusion and atrophy in mild cognitive impairment (MCI) and early Alzheimer's dementia

Psychiatry Research - Neuroimaging

Volumn 183, Issue 1, 2010, Pages 44-51

  Luckhaus, Christian ^a   Cohnen, Mathias ^b   Flüss, Michael Oliver ^c   Jänner, Michaela ^a   Grass Kapanke, Brigitte ^d   Teipel, Stefan J ^e,f   Grothe, Michel ^e,g   Hampel, Harald ^h,i   Peters, Oliver ^j   Kornhuber, Johannes ^k   Maier, Wolfgang ^l   Supprian, Tillmann ^a   Gaebel, Wolfgang ^a   Mödder, Ulrich ^c   Wittsack, Hans Jörg ^c  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b Lukaskrankenhaus GmbH   (Germany)

^c Department of Radiology and Nuclear Medicine   (Germany)

^d Krankenhaus Maria Hilf   (Germany)

^e UNIVERSITY OF ROSTOCK   (Germany)

^f GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^g UNIVERSIDAD PABLO DE OLAVIDE   (Spain)

^h UNIVERSITY OF MUNICH   (Germany)

ⁱ ADELAIDE AND MEATH HOSPITAL   (Ireland)

^j HUMBOLDT UNIVERSITY   (Germany)

^k UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^l UNIVERSITY OF BONN   (Germany)

more..

Author keywords

Alzheimer's disease; Amygdala; APOE; Apolipoprotein E; Atrophy; Brain volume; Cerebral blood flow; Cerebral perfusion; Dementia; Hippocampus; MCI; Mild cognitive impairment

Indexed keywords

APOLIPOPROTEIN E; DNA;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; AMYGDALOID NUCLEUS; ARTICLE; BRAIN ATROPHY; BRAIN BLOOD FLOW; BRAIN PERFUSION; BRAIN SIZE; CLINICAL ARTICLE; DISEASE ASSOCIATION; FEMALE; GENETIC RISK; GENOTYPE; HIPPOCAMPUS; HUMAN; HYPOTHESIS; MALE; MILD COGNITIVE IMPAIRMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PERFUSION WEIGHTED IMAGING; PRIORITY JOURNAL; VOLUMETRY;

AGED; ALZHEIMER DISEASE; APOLIPOPROTEINS E; ATROPHY; BRAIN; BRAIN MAPPING; CEREBROVASCULAR CIRCULATION; COGNITION DISORDERS; COHORT STUDIES; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; STATISTICS, NONPARAMETRIC;

EID: 77954029403     PISSN: 09254927     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pscychresns.2010.04.003     Document Type: Article

References (51)

1. Basso M., Yang J., Warren L., MacAvoy M.G., Varma P., Bronen R.A., van Dyck C.H. Volumetry of amygdala and hippocampus and memory performance in Alzheimer's disease. Psychiatry Research: Neuroimaging 2006, 146:251-261.
2. Chételat G., Desgranges B., Landeau B., Mézenge F., Poline J.B., de la Sayette V., Viader F., Eustache F., Baron J.-C. Direct voxel-based comparison between grey matter hypometabolism and atrophy in Alzheimer's disease. Brain 2008, 131:60-71.
3. Colliot O., Chételat G., Chupin M., Desgranges B., Magnin B., Benali H., Dubois B., Garnero L., Eustache F., Lehéricy S. Discrimination between Alzheimer disease, mild cognitive impairment, and normal aging by using automated segmentation of the hippocampus. Neuroradiology 2008, 248:194-201.
4. Devanand D.P., Pradhaban G., Liu X., Khandji A., De Santi S., Segal S., Rusinek H., Pelton G.H., Honig L.S., Mayeux R., Stern Y., Tabert M.H., de Leon M.J. Hippocampal and entorhinal atrophy in mild cognitive impairment. Prediction of Alzheimer disease. Neurology 2007, 68:828-836.
5. Duarte A., Hayaska S., Du A., Schuff N., Jahng G.-H., Kramer J., Miller B., Weiner M. Volumetric correlates of memory and executive function in normal elderly, mild cognitive impairment and Alzheimer's disease. Neuroscience Letters 2006, 406:60-65.
6. Fakhri G.E., Kijewski M.F., Johnson K.A., Syrkin G., Killiany R.J., Becker J.A., Zimmermann R.E., Albert M.S. MRI-guided SPECT perfusion measures and volumetric MRI in prodromal Alzheimer disease. Archives of Neurology 2003, 60:1066-1072.
7. Folstein M.F., Folstein S.E., McHugh P.R. Mini Mental State: a practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research 1975, 12:189-198.
8. Förstl H., Czech C., Sattel H., Geiger-Kabisch C., Besthorn C., Kreger S., Mönning U., Hartmann T., Masters C., Beyreuther K. Apolipoprotein E und Alzheimer Demenz. Nervenarzt 1994, 65:780-786.
9. Gould R.L., Brown R.G., Owen A.M., Bullmore E.T., Williams S.C.R., Howard R.J. Functional neuroanatomy of successful paired associate learning in Alzheimer's disease. American Journal of Psychiatry 2005, 162:2049-2060.
10. Hampel H., Bürger K., Teipel S.J., Bokde A.L.W., Zetterberg H., Blennow K. Core candidate neurochemical and imaging biomarkers of Alzheimer's disease. Alzheimer's & Dementia 2008, 4:38-48.
11. WMS-R Wechsler Gedächtnistest - revidierte Fassung. Deutsche Adaption der Wechsler Memory Scale 2000, Verlag Hans Huber, Bern, Göttingen. C. Härting, H.J. Markowitsch, H. Neufeld (Eds.).
12. Hashimoto M., Yasuda M., Tanimukai S., Matsui M., Girono N., Kazui H., Mori E. Apolipoprotein E ipsilon 4 and the pattern of regional brain atrophy in Alzheimer's disease. Neurology 2001, 57:1461-1466.
13. Hindmarch I., Lehfeld H., Jongh P., Erzigkeit H. The Bayer Activities of Daily Living Scale (B-ADL). Dementia and Geriatric Cognitive Disorders 1998, 9(Suppl. 2):20-26.
14. Hixon J.E., Vernier D.T. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. Journal of Lipid Research 1990, 31:545-548.
15. Horínek D., Petrovicky P., Hort J., Krásensky J., Brabec J., Bojar M., Vanecková M., Seidl Z. Amygdalar volume and psychiatric symptoms in Alzheimer's disease: an MRI analysis. Acta Neurologica Scandinavica 2006, 113:40-45.
16. Horínek D., Varjassyova A., Hort J. Magnetic resonance analysis of amygdalar volume in Alzheimer's disease. Current Opinion in Psychiatry 2007, 20:273-277.
17. Ihl R., Frölich L. Die Reisberg-Skalen 1991, Beltz Verlag, Weinheim.
18. Ihl R., Grass-Kapanke B. Manual - Test zur Früherkennung von Demenzen mit Depressionsabgrenzung 2000, Libri Books on Demand, Hamburg.
19. Ishiwata A., Sakayori O., Minoshima S., Mizumura S., Kitamura S., Katayama Y. Preclinical evidence of Alzheimer changes in progressive mild cognitive impairment: a qualitative and quantitative SPECT study. Acta Neurologica Scandinavica 2006, 114:91-96.
20. Johnson K.A., Jones K., Holman B.L., Becker J.A., Spiers P.A., Satlin A., Albert M.S. Preclinical prediction of Alzheimer's disease using SPECT. Neurology 1998, 50:1563-1571.
21. Johnson N.A., Jahng G.-H., Weiner M.W., Miller B.L., Chui H.C., Jagust W.J., Gorno-Tempini M.L., Schuff N. Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: Initial experience. Radiology 2005, 234:851-859.
22. Jorm A. A short form of the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): development and cross-validation. Psychological Medicine 1994, 24:145-153.
23. Kaufmann L., Ischebeck A., Weiss E., Koppelstaetter F., Siedentopf C., Volgel S.E., Gotwald T., Marksteiner J., Wood G. An fMRI study of the numerical Stroop task in individuals with and without minimal cognitive impairment. Cortex 2008, 44:1248-1255.
24. Kertesz A., Nadkarni N., Davidson W., Thomas A.W. The Frontal Behavioral Inventory in the differential diagnosis of frontotemporal dementia. Journal of the International. Neuropsychological Society 2000, 6:460-468.
25. Kornhuber J., Schmidtke K., Frölich L., Kurz A., Wolf S., Hampel H., Jessen F., Heuser I., Peters O., Weih M., Jahn H., Luckhaus C., Hüll M., Gertz H.-J., Schröder J., Pantel J., Rienhoff O., Seuchter S.A., Rüther E., Henn F., Meier W., Wiltfang J. Early and differential diagnosis of dementia and MCI: design and cohort baseline characteristics of the German Competence Net Dementias. Dementia, Geriatric and Cognitive Disorders 2009, 27:404-417.
26. Leenders K.L., Perani D., Lammertsma A.A., Heather J.D., Buckingham P., Healy M.J., Gibbs J.M., Wise R.J., Hatazawa J., Herold S., Beaney R.P., Brooks D.J., Spinks T., Rhodes C., Frackowiak R.S.J. Cerebral blood flow, blood volume and oxygen utilization. Normal values and effect of age. Brain 1990, 113:27-47.
27. Lehtovirta M., Laako M.P., Soininen H., Helisalmi S., Mannermaa A., Helkala E.-L., Partanen K., Ryynänen M., Vainio P., Hartikainen P., Riekinen P.J. Volumes of hippocampus, amygdale and frontal lobe in Alzheimer patients with different apolipoprotein E genotypes. Neuroscience 1995, 67:65-72.
28. Lehtovirta M., Kuikka J., Helisalmi S., Hartikainen P., Mannermaa A., Ryynänen M., Riekkinen P., Soininen H. Longitudinal SPECT study in Alzheimer's disease: relation to apolipoprotein E polymorphism. Journal of Neurology, Neurosurgery and Psychiatry 1998, 64:742-746.
29. Luckhaus C., Flüβ M.O., Wittsack H.-J., Grass-Kapanke B., Jänner M., Khalili-Amiri R., Friedrich W., Supprian T., Gaebel W., Mödder U., Cohnen M. Detection of changed regional cerebral blood flow in mild cognitive impairment and early Alzheimer's dementia by perfusion-weighted magnetic resonance imaging. Neuroimage 2008, 40:495-503.
30. Marien P., Engelborghs S., Fabbro F., De Deyn P.P. The lateralized linguistic cerebellum: a review and a new hypothesis. Brain and Language 2001, 79:580-600.
31. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984, 34:939-944.
32. Modrego P.J. Predictors of conversion to dementia of probable Alzheimer type in patients with mild cognitive impairment. Current Alzheimer Research 2006, 3:161-170.
33. Morris J.C. The Clinical Dementia Rating (CDR): Current version and scoring rules. Neurology 1997, 43:2412-2414.
34. Moscovitch M., Rosenbaum R.S., Gilboa A., Addis D.R., Westmacott R., Grady C., McAndrews M.P., Levine B., Black S., Winocur G., Nadel L. Functional neuroanatomy of remote episodic, semantic and spatial memory: a unified account based on multiple trace theory. Journal of Anatomy 2005, 207:35-66.
35. Ostergaard L., Weisskoff R.M., Chesler D.A., Gyldensted C., Rosen B.R. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I: Mathematical approach and statistical analysis. Magnetic Resonance in Medicine 1996, 36:715-725.
36. Ostergaard L., Sorensen A.G., Kwong K.K., Weisskoff R.M., Gyldensted C., Rosen B.R. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part II: Experimental comparison and preliminary results. Magnetic Resonance in Medicine 1996, 36:726-736.
37. Pantano P., Baron J.C., Samson Y., Bousser M.G., Derouesne C., Comar D. Crossed cerebellar diaschisis. Brain 1986, 109:677-694.
38. Pennanen C., Testa C., Boccardi M., Laasko M.P., Hallikainen M., Helkala E.-L., Hänninen T., Kivipelto M., Könönen M., Nissinen A., Tervo S., Vanhanen M., Vanninen R., Frisoni G.B., Soininen H. The effect of apolipoprotein polymorphism on brain in mild cognitive impairment: a voxel-based morphometric study. Dementia and Geriatric Cognitive Disorders 2006, 22:60-66.
39. Petersen R.C., Smith G.E., Waring S.C., Ivnik R.J., Tangalos E.G., Kokmen E. Mild cognitive impairment. Clinical characterization and outcome. Archives of Neurology 1999, 56:303-308.
40. Petersen R.C., Doody R., Kurz A., Mohs R.C., Morris J.C., Rabins P.V., Ritchie K., Rossor M., Thal L., Winblad B. Current concepts in mild cognitive impairment. Archives of Neurology 2001, 58:1985-1992.
41. Pruessner J.C., Li L.M., Serles W., Pruessner M., Collins D.L., Kabani N., Lupien S., Evans A.C. Volumetry of hippocampus and amydala with high-resolution MRI and three-dimensional analysis software: minimizing the discrepancies between laboratories. Cerebral Cortex 2000, 10:433-442.
42. Reitan R.M. Trail Making Test (TMT) 1979, Hogrefe Verlag, Bern, Göttingen.
43. Sakamoto S., Matsuda H., Asada T., Ohnishi T., Nakano S., Kanetaka H., Takasaki M. Apolipoprotein E genotype and early Alzheimer's disease: a longitudinal SPECT study. Journal of Neuroimaging 2003, 13:113-123.
44. Saunders A.M., Trowers M.K., Shimkets R.A., Blakemore S., Crowther D.J., Mansfield T.A., Wallace D.M., Strittmatter W.J., Roses A.D. The role of apolipoprotein E in Alzheimer's disease: pharmacogenomic target selection. Biochimica et Biophysica Acta 2000, 1502:85-94.
45. Shulman K.I. Clock-drawing: is it the ideal cognitive screening test?. International Journal of Geriatric Psychiatry 2000, 15:548-561.
46. Teipel S.J., Born C., Ewers M., Bokde A.L.W., Reiser M.F., Möller H.-J., Hampel H. Multivariate deformation-based analysis of brain atrophy to predict Alzheimer's disease in mild cognitive impairment. Neuroimage 2007, 38:13-24.
47. Thalmann B., Monsch A.U., Bernasconi F., Berres M., Schneitter M., Ermini-Fuenfschilling D., Spiegel R., Staehelin H.B. Die CERAD Neuropsychologische Testbatterie - Ein gemeinsames minimales Instrumentarium zur Demenzabklärung. Memory Clinic, Geriatrische Universitätsklinik Basel 1998.
48. Trollor J.N., Sachdev P.S., Haindl W., Brodaty H., Wen W., Walker B.M. A high-resolution single photon emission computed tomography study of verbal recognition memory in Alzheimer's disease. Dementia and Geriatric Cognitive Disorders 2006, 21:267-274.
49. van de Pol L.A., Korf E.S., van der Flier W.M., Brashear H.R., Fox N.C., Barkhof F., Scheltens P. Magnetic resonance imaging predictors of cognition in mild cognitive impairment. Archives of Neurology 2007, 64:1023-1028.
50. Villain N., Desgranges B., Viader F., de la Sayette V., Mézenge F., Landeau B., Baron J.-C., Eustache F., Chételat G. Relationships between hippocampal atrophy, white matter disruption, and gray matter hypometabolism in Alzheimer's disease. Journal of Neuroscience 2008, 28:6174-6181.
51. Wang L., Zang Y., He Y., Liang M., Zhang X., Tian L., Wu T., Jiang T., Li K. Changes in hippocampal connectivity in the early stages of Alzheimer's disease: evidence from resting state fMRI. Neuroimage 2006, 31:496-504.